Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis

American Journal of Surgery

Volumn 205, Issue 6, 2013, Pages 685-690

  Bower, Matthew ^a   Wunderlich, Chris ^b   Brown, Russell ^a   Scoggins, Charles R ^a   McMasters, Kelly M ^a   Martin, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

^b Norton Hospital   (United States)

Author keywords

Chemotherapy; Colorectal metastasis; Liver failure; Steatosis

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; COLORECTAL LIVER METASTASIS; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMAN; INSTITUTIONAL REVIEW; LIVER INJURY; LIVER RESECTION; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK FACTOR; SEX; SLEEP DISORDERED BREATHING; SMOKING;

ANTINEOPLASTIC AGENTS; BODY MASS INDEX; COLORECTAL NEOPLASMS; FATTY LIVER; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; OBESITY;

EID: 84877806342     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2012.07.034     Document Type: Article

References (36)

1. T.A. Aloia, J.N. Vauthey, and E.M. Loyer Solitary colorectal liver metastasis: resection determines outcome Arch Surg 141 2006 460 466 discussion 466-7
2. E.K. Abdalla, J.N. Vauthey, and L.M. Ellis Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 2004 818 825 discussion 825-7
3. T.M. Pawlik, C.R. Scoggins, and D. Zorzi Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases Ann Surg 241 2005 715 722 discussion 722-4
4. M.A. Choti, J.V. Sitzmann, and M.F. Tiburi Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 2002 759 766
5. S. Kopetz, P.M. Hoff, and J.S. Morris Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance J Clin Oncol 28 2010 453 459
6. A. de Gramont, A. Figer, and M. Seymour Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2000 2938 2947
7. H. Hurwitz, L. Fehrenbacher, and W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
8. C. Bokemeyer, I. Bondarenko, and A. Makhson Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer J Clin Oncol 27 2009 663 671
9. R. Adam, E. Avisar, and A. Ariche Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal Ann Surg Oncol 8 2001 347 353
10. R. Adam, V. Delvart, and G. Pascal Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 2004 644 657 discussion 657-8
11. S. Giacchetti, M. Itzhaki, and G. Gruia Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery Ann Oncol 10 1999 663 669
12. G. Folprecht, T. Gruenberger, and W.O. Bechstein Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial Lancet Oncol 11 2010 38 47
13. B. Nordlinger, H. Sorbye, and B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016
14. T. Aloia, M. Sebagh, and M. Plasse Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases J Clin Oncol 24 2006 4983 4990
15. M. Karoui, C. Penna, and M. Amin-Hashem Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 243 2006 1 7
16. C.R. Scoggins, M.L. Campbell, and C.S. Landry Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases Ann Surg Oncol 16 2009 35 41
17. G. Morris-Stiff, Y.M. Tan, and J.N. Vauthey Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases Eur J Surg Oncol 34 2008 609 614
18. A. Sahajpal, C.M. Vollmer Jr., and E. Dixon Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes J Surg Oncol 95 2007 22 27
19. S. Yedibela, L. Elad, and A. Wein Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases Eur J Surg Oncol 31 2005 141 146
20. O. Soubrane, A. Brouquet, and S. Zalinski Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome Ann Surg 251 2010 454 460
21. H. Nakano, E. Oussoultzoglou, and E. Rosso Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 2008 118 124
22. A. Brouquet, S. Benoist, and C. Julie Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases Surgery 145 2009 362 371
23. F.G. Fernandez, J. Ritter, and J.W. Goodwin Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases J Am Coll Surg 200 2005 845 853
24. C.P. Day, and O.F. James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845
25. J.N. Vauthey, T.M. Pawlik, and D. Ribero Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2006 2065 2072
26. W.H. Organization Obesity: Preventing and Managing the Global Epidemic 1998 World Health Organization Geneva, Switzerland
27. M. Bower, W. Jones, and B. Vessels Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy Ann Surg Oncol 16 2009 3161 3168
28. D.E. Kleiner, E.M. Brunt, and M. Van Natta Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
29. L. Rubbia-Brandt, V. Audard, and P. Sartoretti Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol 15 2004 460 466
30. CDC Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1976-80 Through 2005-2006 2008 US Department of Health and Human Services, National Center for Health Statistics Hyattsville, MD
31. T.M. Pawlik, K. Olino, and A.L. Gleisner Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome J Gastrointest Surg 11 2007 860 868
32. M. Klinger, S. Eipeldauer, and S. Hacker Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases Eur J Surg Oncol 35 2009 515 520
33. S. Pathak, J.M. Tang, and M. Terlizzo Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases Eur J Surg Oncol 36 2010 52 57
34. D.A. Kooby, Y. Fong, and A. Suriawinata Impact of steatosis on perioperative outcome following hepatic resection J Gastrointest Surg 7 2003 1034 1044
35. J.T. Mullen, D.L. Davenport, and M.M. Hutter Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery Ann Surg Oncol 15 2008 2164 2172
36. A.K. Mathur, A.A. Ghaferi, and K. Sell Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy J Gastrointest Surg 14 2010 849 857